Showing 338 results for "risdiplam"

Apitegromab Showing Potential to Ease Fatigue, Aid Life Quality

Continued treatment with apitegromab, designed to strengthen muscles, led to stabilization or improvement in measures of fatigue and life quality for children and young adults with types 2 and 3 spinal muscular atrophy (SMA), according to new data from the TOPAZ clinical trial. According to apitegromab’s developer…

SMA Patients, Caregivers Surveyed About Switching to Evrysdi

Children with spinal muscular atrophy (SMA) switching from Spinraza (nusinersen) to Evrysdi (risdiplam) are generally optimistic about the switch as are their caregivers, according to a new study. The report, “How children and caregivers viewed the change from nusinersen to risdiplam for treating spinal…

Evrysdi Found to Help Previously Treated SMA Patients in Trial

Treatment with Evrysdi (risdiplam) increased levels of SMN protein and stabilized motor function in a Phase 2 clinical trial that enrolled spinal muscular atrophy (SMA) patients who had previously been on other therapies, two-year data show. “These important data demonstrate the safety and efficacy of Evrysdi in a…

Double Take, SMA Runway Show, Features Styles With Accessibility

New York Fashion Week is known for its statement dresses and elegant models. But this year, one runway show will be slightly different, featuring people in wheelchairs wearing clothes designed for both fashion and accessibility. Models with spinal muscular atrophy (SMA) will drive down the runway on Sept. 8…